Kimberly Hess
Adult Health · New Bern, NCNPI 1831496181
Payments from drug & device makers
Across 125 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$332
- Johnson & Johnson$262
- Dendreon Pharmaceuticals LLC$257
- AstraZeneca$158
- Sanofi$149
- Seagen Inc.$142
- plus $1K from 34 others
What the payments were for
- Food & beverage$2,56893%
- Education$1997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 15 | $332 |
| Johnson & Johnson | 9 | $262 |
| Dendreon Pharmaceuticals LLC | 11 | $257 |
| AstraZeneca | 7 | $158 |
| Sanofi | 6 | $149 |
| Seagen Inc. | 4 | $142 |
| Pfizer | 7 | $131 |
| Daiichi Sankyo Inc. | 3 | $130 |
| E.r. Squibb & Sons, L.L.C. | 3 | $114 |
| Novartis | 5 | $110 |
| Bristol Myers Squibb | 6 | $94 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Eisai Inc. | 4 | $64 |
| Array Biopharma Inc | 4 | $62 |
| Incyte Corporation | 4 | $61 |
| Genentech USA, Inc. | 2 | $44 |
| Sobi, Inc | 1 | $41 |
| Beigene USA, Inc. | 2 | $41 |
| AbbVie | 2 | $39 |
| Amgen | 2 | $37 |
| Pharmaessentia USA Corporation | 2 | $36 |
| Agios Pharmaceuticals, Inc. | 2 | $35 |
| Karyopharm Therapeutics Inc. | 2 | $30 |
| Stemline Therapeutics Inc. | 1 | $30 |
| Pharmacosmos Therapeutics Inc. | 2 | $27 |
| Fennec Pharmaceuticals, Inc. | 1 | $25 |
| Sirtex Medical Inc | 2 | $24 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Taiho Oncology, Inc. | 1 | $22 |
| Bayer | 1 | $22 |
| Blue Earth Diagnostics | 1 | $19 |
| Coherus Oncology, Inc. | 1 | $18 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| GSK | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| ADC Therapeutics America, Inc. | 1 | $15 |
| Tersera Therapeutics LLC | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Exelixis Inc. | 1 | $12 |
How this compares
$2,767 in reported general payments places this provider in the 80th percentile of 614 adult health providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 13 | $234 |
| Letrozole | 11 | $109 |
| Potassium Chloride | 15 | $82 |
| Pantoprazole Sodium | 15 | $53 |
Paid to pharmacies, not to this prescriber.
Other adult health in New Bern
- Dawnelle HoladiaNew Bern$7K
- Robert DodgeRaleigh$311K
- Kimberly CampDurham$147K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
- Felicia RichardsonGreenville$64K
- Anna BooneReidsville$51K
- Chaely MedleyChapel Hill$47K
- Ann ShumDurham$35K
- Amy HopkinsGreenville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.